Data Transparency and Clinical Trial Reports to the EMA: A Compliance Guide
The EMA believes that making clinical trial results publicly accessible enhances scientific discourse, supports healthcare decision-making, and prevents duplication of efforts. By enforcing transparency, the agency also encourages good clinical practice and ethical conduct in pharmaceutical development.
Click to read the full article.